DeepMed Research

CDC ENTEBBE

🇺🇬Uganda

Country: 🇺🇬Uganda

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis

Completed

Conditions: Latent Tuberculosis Infection
Tuberculosis

First Posted Date: 2012-06-18

Last Posted Date: 2021-01-28

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 21334

Registration Number: NCT01622140

Locations: 🇺🇸
University of North Texas Health Science Center, Fort Worth, Texas, United States
🇺🇸
California Department of Public Health, Richmond, California, United States
🇺🇸
Maricopa County Department of Public Health, Phoenix, Arizona, United States

and more 7 locations

Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT

Phase 3

Completed

Conditions: Latent Tuberculosis Infection

Interventions: Behavioral: Self Administered Therapy (SAT)
Drug: isoniazid and rifapentine
Behavioral: SMS reminders

First Posted Date: 2012-04-23

Last Posted Date: 2025-03-13

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 1002

Registration Number: NCT01582711

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Denver Public Health Department, Denver, Colorado, United States
🇺🇸
Columbia University College of Physicians and Surgeons and New York City Department of Health, New York, New York, United States

and more 9 locations

Diarrhea and Bivalent Oral Polio Vaccine Immunity

Not Applicable

Completed

Conditions: Polio
Seroimmunity
Diarrhea

Interventions: Biological: bivalent oral polio vaccine

First Posted Date: 2012-03-21

Last Posted Date: 2015-10-15

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 699

Registration Number: NCT01559636

Locations: 🇳🇵
Institute of Medicine, Kathmandu, Nepal

Pakistan Flocculent Health Outcome Study

Not Applicable

Completed

Conditions: Diarrhea

Interventions: Other: handwashing
Other: water treatment with sodium hypochlorite
Other: flocculent-disinfectant for water treatment

First Posted Date: 2012-02-27

Last Posted Date: 2012-02-27

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 8949

Registration Number: NCT01538953

Locations: 🇵🇰
Health-Oriented Preventive Education, Karachi, Pakistan

Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand

Phase 4

Completed

Conditions: Influenza

Interventions: Biological: Intradermal vaccine
Biological: Intramuscular vaccine

First Posted Date: 2012-02-27

Last Posted Date: 2024-06-05

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 415

Registration Number: NCT01538940

Locations: 🇹🇭
Silom Community Clinic, Bangkok, Thailand

Intervention to Retain HIV-positive Patients in Medical Care

Not Applicable

Completed

Conditions: Primary Care Appointment Keeping

Interventions: Behavioral: Enhanced contact only
Behavioral: Enhanced contact plus behavioral skills
Behavioral: Standard of Care

First Posted Date: 2012-02-23

Last Posted Date: 2013-09-09

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 1838

Registration Number: NCT01537367

Locations: 🇺🇸
Boston University Medical Center, HIV Clinic, Boston, Massachusetts, United States
🇺🇸
SUNY Downstate Medical Center, STAR Health Center, Brooklyn, New York, United States
🇺🇸
1917 Clinic of the University of Alabama-Birmingham, Birmingham, Alabama, United States

and more 3 locations

Seasonal Influenza Vaccine Effectiveness Study in Kenya

Conditions: Severe Acute Respiratory Illness
Influenza
Influenza Like Illness

Interventions: Biological: Seasonal influenza vaccine

First Posted Date: 2011-09-12

Last Posted Date: 2011-09-12

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 10000

Registration Number: NCT01432340

Locations: 🇰🇪
KEMRI/CDC- IEIP surveillance-Asembo, Kisumu, Western, Kenya
🇰🇪
KEMRI/CDC IEIP surveillance- Kibera, Nairobi, Kenya

Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi

Not Applicable

Completed

Conditions: Malaria, Falciparum

Interventions: Drug: Artesunate-amodiaquine combination
Drug: Dihydroartemisinin-piperaquine
Drug: Artemether-lumefantrine combination

First Posted Date: 2011-03-31

Last Posted Date: 2013-02-25

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 498

Registration Number: NCT01326754

Locations: 🇲🇼
Machinga District Hospital, Liwonde, Malawi

A Methadone Maintenance Treatment Outcome Study in Three Provinces in China

Not Applicable

Completed

Conditions: Hepatitis C
Herpes Simplex Type II
HIV
Syphilis

Interventions: Other: national guidelines
Behavioral: MMT provider dosage training
Behavioral: targeted counseling

First Posted Date: 2011-03-15

Last Posted Date: 2024-08-22

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 4258

Registration Number: NCT01315054

Locations: 🇨🇳
National Center for HIV/STD Prevention and Control, China CDC, Beijing, China

A Computer-based Intervention to Augment Home Visitation Services: The E-Parenting Project

Not Applicable

Completed

Conditions: Child Maltreatment

Interventions: Behavioral: Computer Assisted Healthy Families America Home Visitation
Behavioral: Healthy Families America Home Visitation

First Posted Date: 2011-02-25

Last Posted Date: 2013-05-15

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 413

Registration Number: NCT01304719

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy